DNA damage repair is unaffected by mimicked heterozygous levels of BRCA2 in HT-29 cells

International Journal of Biological Sciences

Volumn 3, Issue 7, 2007, Pages 402-407

  Tannenbaum, Brian ^a   Mofunanya, Tobechukwu ^a   Schoenfeld, Alan R ^a  

^a ADELPHI UNIVERSITY   (United States)

Author keywords

BRCA2; DNA damage repair; Heterozygosity; RNAi

Indexed keywords

BRCA2 PROTEIN; MITOMYCIN C; PROTEIN P27; PROTEIN P53; RAD51 PROTEIN;

ALLELE; ARTICLE; CANCER CELL; CELL CULTURE; CELL CYCLE; CELL STRAIN HT29; CELL SURVIVAL; CELLULAR DISTRIBUTION; COLON; COLON CANCER; CONTROLLED STUDY; DNA DAMAGE; DNA REPAIR; GROWTH RATE; HETEROZYGOSITY; HUMAN; HUMAN CELL; INFORMATION PROCESSING; MOLECULAR MIMICRY; PROTEIN DEFICIENCY; PROTEIN EXPRESSION; PROTEIN FUNCTION; RNA INTERFERENCE; TUMOR; ULTRAVIOLET RADIATION; WILD TYPE;

EID: 35148825472     PISSN: 14492288     EISSN: None     Source Type: Journal    
DOI: 10.7150/ijbs.3.402     Document Type: Article

References (24)

1. Wooster R, Bignell G, Lancaster J et al. Identification of the breast cancer susceptibility gene BRCA2. Nature 1995, 378(6559):789-792.
2. Risch HA, McLaughlin JR, Cole DE et al. Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer. Am J Hum Genet 2001, 68(3):700-710.
3. Berman DB, Costalas J, Schultz DC et al. A common mutation in BRCA2 that predisposes to a variety of cancers is found in both Jewish Ashkenazi and non-Jewish individuals. Cancer Res 1996, 56(15):3409-3414.
4. Collins N, McManus R, Wooster R et al. Consistent loss of the wild type allele in breast cancers from a family linked to the BRCA2 gene on chromosome 13q12-13. Oncogene 1995, 10(8):1673-1675.
5. Tavtigian SV, Simard J, Rommens J et al. The complete BRCA2 gene and mutations in chromosome 13q-linked kindreds. Nat Genet 1996, 12(3):333-337.
6. Sharan SK, Morimatsu M, Albrecht U et al. Embryonic lethality and radiation hypersensitivity mediated by Rad51 in mice lacking Brca2. Nature 1997, 386(6627):804-810.
7. Chen PL, Chen CF, Chen Y et al. The BRC repeats in BRCA2 are critical for RAD51 binding and resistance to methyl methanesulfonate treatment. Proc Natl Acad Sci USA 1998, 95(9):5287-5292.
8. Patel KJ, Yu VP, Lee H et al. Involvement of Brca2 in DNA repair. Mol Cell 1998, 1(3):347-357.
9. Yu VP, Koehler M, Steinlein C et al. Gross chromosomal rearrangements and genetic exchange between nonhomologous chromosomes following BRCA2 inactivation. Genes Dev 2000, 14(11):1400-1406.
10. Godthelp BC, van Buul PP, Jaspers NG et al. Cellular characterization of cells from the Fanconi anemia complementation group, FA-D1/BRCA2. Mutat Res 2006, 601(1-2):191-201.
11. Tutt A, Gabriel A, Bertwistle D et al. Absence of Brca2 causes genome instability by chromosome breakage and loss associated with centrosome amplification. Curr Biol 1999, 9(19):1107-1110.
12. Moynahan ME, Pierce AJ, Jasin M. BRCA2 is required for homology-directed repair of chromosomal breaks. Mol Cell 2001, 7(2):263-272.
13. Tutt A, Bertwistle D, Valentine J et al. Mutation in Brca2 stimulates error-prone homology-directed repair of DNA double-strand breaks occurring between repeated sequences. Embo J 2001, 20(17):4704-4716.
14. Davies AA, Masson JY, McIlwraith MJ et al. Role of BRCA2 in control of the RAD51 recombination and DNA repair protein. Mol Cell 2001, 7(2):273-282.
15. Knudson AGJr. Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci U S A 1971, 68(4):820-823.
16. Warren M, Lord CJ, Masabanda J et al. Phenotypic effects of heterozygosity for a BRCA2 mutation. Hum Mol Genet 2003, 12(20):2645-2656.
17. Kim MK, Zitzmann S, Westermann F et al. Increased rates of spontaneous sister chromatid exchange in lymphocytes of BRCA2+/- carriers of familial breast cancer clusters. Cancer Lett 2004, 210(1):85-94.
18. Arnold K, Kim MK, Frerk K et al. Lower level of BRCA2 protein in heterozygous mutation carriers is correlated with an increase in DNA double strand breaks and an impaired DSB repair. Cancer Lett 2006, 243(1):90-100.
19. Brummelkamp TR, Bernards R, Agami R. Stable suppression of tumorigenicity by virus-mediated RNA interference. Cancer Cell 2002, 2(3):243-247.
20. Schoenfeld AR, Apgar S, Dolios G et al. BRCA2 is ubiquitinated in vivo and interacts with USP11, a deubiquitinating enzyme that exhibits prosurvival function in the cellular response to DNA damage. Mol Cell Biol 2004, 24(17):7444-7455.
21. Naviaux RK, Costanzi E, Haas M et al. The pCL vector system: rapid production of helper-free, high-titer, recombinant retroviruses. J Virol 1996, 70(8):5701-5705.
22. Yuan SS, Lee SY, Chen G et al. BRCA2 is required for ionizing radiation-induced assembly of Rad51 complex in vivo. Cancer Res 1999, 59(15):3547-3551.
23. Connor F, Bertwistle D, Mee PJ et al. Tumorigenesis and a DNA repair defect in mice with a truncating Brca2 mutation. Nat Genet 1997, 17(4):423-430.
24. Jonkers J, Meuwissen R, van der Gulden H et al. Synergistic tumor suppressor activity of BRCA2 and p53 in a conditional mouse model for breast cancer. Nat Genet 2001, 29(4):418-425.